These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2632646)

  • 1. Capillary filtration and lymphatic resorption in diabetes. Application to the pharmacodynamic activity of Daflon 500 mg.
    Behar A; Valensi P; de Champvallins M; Cohen-Boulakia F; Albagli B
    Int Angiol; 1989; 8(4 Suppl):27-9. PubMed ID: 2632646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a purified micronized flavonoid fraction on capillary filtration in diabetic patients.
    Valensi PE; Behar A; de Champvallins MM; Attalah M; Boulakia FC; Attali JR
    Diabet Med; 1996 Oct; 13(10):882-8. PubMed ID: 8911782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of capillary filtration by double labelling I131-albumin and Tc99m red cells. Application to the pharmacodynamic activity of Daflon 500 mg.
    Behar A; Lagrue G; Cohen-Boulakia F; Baillet J
    Int Angiol; 1988; 7(2 Suppl):35-8. PubMed ID: 3053941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capillary filtration in idiopathic cyclic edema--effects of Daflon 500 mg.
    Behar A; Lagrue G; Cohen-Boulakia F; Baillet J
    Nuklearmedizin; 1988 Jun; 27(3):105-7. PubMed ID: 3043383
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased capillary permeability to albumin and diabetic neuropathy.
    Valensi P; Attali JR; Behar A; Attalah M; Sebaoun J
    Diabetes Res Clin Pract; 1991 Jan; 11(1):41-6. PubMed ID: 2019234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic properties of Daflon 500 mg.
    Labrid C
    Angiology; 1994 Jun; 45(6 Pt 2):524-30. PubMed ID: 8203782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capillary endothelial but not lymphatic function is restored under rosiglitazone in Zucker diabetic fatty rats.
    Cosson E; Cohen-Boulakia F; Tarhzaoui K; Dabiré H; Léger G; Charnaux N; Lestrade R; Behar A; Valensi P
    Microvasc Res; 2009 Mar; 77(2):220-5. PubMed ID: 19109983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different flavonoids present in the micronized purified flavonoid fraction (Daflon 500 mg) contribute to its anti-hyperpermeability effect in the hamster cheek pouch microcirculation.
    Paysant J; Sansilvestri-Morel P; Bouskela E; Verbeuren TJ
    Int Angiol; 2008 Feb; 27(1):81-5. PubMed ID: 18277344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo sequential study of skeletal muscle capillary permeability in diabetic rats: effect of anthocyanosides.
    Cohen-Boulakia F; Valensi PE; Boulahdour H; Lestrade R; Dufour-Lamartinie JF; Hort-Legrand C; Behar A
    Metabolism; 2000 Jul; 49(7):880-5. PubMed ID: 10909999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of veinotonyl 75 on the capillary permeability test using technetium albumin in cyclic orthostatic edemas].
    Behar A; Nathan P; Lavieuville M; Allaert FA
    Phlebologie; 1993; 46(4):721-31. PubMed ID: 8115491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphatic system and microcirculation. Proceedings of the Third International Symposium on Daflon 500 held during the First Mediterranean Congress of Angiology. Corfu, Greece, May 31, 1988.
    Int Angiol; 1989; 8(4 Suppl):1-75. PubMed ID: 2632643
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of Daflon 500 mg on bovine vessels contractility.
    Gargouil YM; Perdrix L; Chapelain B; Gaborieau R
    Int Angiol; 1989; 8(4 Suppl):19-22. PubMed ID: 2632645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A lymphatic function of Daflon 500 mg.
    Labrid C
    Int Angiol; 1995 Sep; 14(3 Suppl 1):36-8. PubMed ID: 8919263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advantage of a micronized flavonoidic fraction (Daflon 500 mg) in comparison with a nonmicronized diosmin.
    Amato C
    Angiology; 1994 Jun; 45(6 Pt 2):531-6. PubMed ID: 8203783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isotopic test of capillary permeability to albumin in diabetic patients: effects of hypertension, microangiopathy, and duration of diabetes.
    Valensi P; Attali JR; Behar A; Sebaoun J
    Metabolism; 1987 Sep; 36(9):834-9. PubMed ID: 3626865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the pharmacodynamic activity of daflon 500 mg].
    Amiel M; Barbe R
    Ann Cardiol Angeiol (Paris); 1998 Mar; 47(3):185-8. PubMed ID: 9772947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of impaired microcirculation.
    Valensi P; Behar A
    Int Angiol; 1995 Sep; 14(3 Suppl 1):26-31. PubMed ID: 8919261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediators involved in inflammation: effects of Daflon 500 mg on their release.
    Jean T; Bodinier MC
    Angiology; 1994 Jun; 45(6 Pt 2):554-9. PubMed ID: 8203787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperfiltration in diabetic patients].
    Khristov V; Petrov T; Nikolov M
    Vutr Boles; 1990; 29(2):70-4. PubMed ID: 2122596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphagogue and pulsatile activities of Daflon 500 mg on canine thoracic lymph duct.
    Cotonat A; Cotonat J
    Int Angiol; 1989; 8(4 Suppl):15-8. PubMed ID: 2632644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.